Trial Details

Not Recruiting
Basic Information
Clinical ID c1996
Identifier ChiCTR2500097177
Trial Title Exploring the impact of sleep disorders on the prognosis of patients with inflammatory bowel disease and the protective effect of melatonin
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Inflammatory bowel disease; Ulcerative colotis; Crohn's disease
Interventions Placebo-controlled group:The placebo control group took 3 mg of placebo tablets of the same size, shape, color, and smell every night at bedtime for three months.;Melatonin intervention group:The intervention group was given melatonin tablets 3mg 2-3 hours before bedtime every night for three months.;
Participant Information
Sponsor Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
City -
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional study
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -